Skip to content

Mindfulness Meditation Intervention for Colorectal Cancer Patients and Caregivers

Being Present: Audio-Based Mindfulness Meditation Intervention for Colorectal Cancer Patients and Caregivers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02423720
Acronym
Mindfulness
Enrollment
53
Registered
2015-04-22
Start date
2015-04-28
Completion date
2017-01-01
Last updated
2018-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Brief summary

This is a audio based mindfulness meditation intervention for colorectal cancer patients and caregivers. A 8-week single arm study will be conducted among University of California, San Francisco (UCSF) patients with metastatic colorectal cancer undergoing chemotherapy and caregivers of these patients (44 participants total).

Detailed description

A metastatic cancer diagnosis is associated with high levels of distress in both patients and caregivers. The investigators hypothesize that an audio-based mindfulness intervention will be an effective means to reduce distress and improve quality of life among patients with advanced cancer and their caregivers. With the Being Present study, conduct an 8-week single arm study among UCSF patients with metastatic colorectal cancer undergoing chemotherapy and caregivers of these patients (44 participants total). Participants will receive an informational booklet containing a practice log and a MP3 player containing an introductory lecture and guided meditations. Practice reminders will be sent via text messages. Emails will contain practice assignments and links to validated survey instruments. The survey instruments (National Comprehensive Cancer Network (NCCN) Distress Thermometer and National Institutes of Health (NIH) Patient Reported Outcomes Measurement Information System (PROMIS) adult short forms) will measure global health, anxiety, depression, fatigue, and sleep quality before, during, and after the intervention to obtain preliminary estimates of the efficacy of the intervention among patients and caregivers on self-reported outcomes. Qualitative data will be collected from pre- and post-intervention interviews.

Interventions

BEHAVIORALAudio-Based Mindfulness

Audio-based mindfulness tracks (MP3 format).

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Eligible patients must: * Carry a diagnosis of metastatic colon, rectum, or small bowel adenocarcinoma * Anticipate receiving chemotherapy for at least 12 weeks total from the time of recruitment * Have life expectancy of at least 6 months * Have Karnofsky Performance Status ≥60 * Be able to speak and read English * Have access to a mobile phone * Be able to navigate websites, fill out forms on the web, communicate by email, and have regular access to the internet * Have a distress level of ≥3 on the NCCN Distress Thermometer (DT).\[1, 40\] * An effort will always be made to recruit patient and caregiver pairs, but unpaired patients are also eligible Eligible caregivers are a spouse/partner, other family member, or a close friend of a patient with metastatic colon, rectum, or small bowel adenocarcinoma. Eligible caregivers must: * Be able to speak and read English * Have access to a mobile phone * Be able to navigate websites, fill out forms on the web, communicate by email, and have regular access to the internet

Exclusion criteria

This study is limited the study to patients with metastatic colon, rectum, or small bowel adenocarcinoma, because treatment regimens and disease trajectories for these disease groups are similar. Deafness, Current meditation practice (\>2 episodes or \>1 hour total, weekly), and current enrollment in a stress reduction program are

Design outcomes

Primary

MeasureTime frame
Proportion of eligible patients and caregivers who agree to be screened, consent to participate, and complete or partially complete the intervention, as a measure of feasibility and acceptability.8 weeks
Adherence to the intervention, as assessed by frequency and duration of practicing the exercises (recorded in a log and responses to text messages)8 weeks

Secondary

MeasureTime frame
Reasons for ineligibility, as a measure of feasibility8 weeks
Proportion of enrolled patients and caregivers who refuse to participate in or complete the intervention, as a measure of feasibility and acceptability8 weeks
Reasons for non-participation/non-continuation of the intervention, as a measure of feasibility and acceptability8 weeks
Adherence to the intervention, as assessed by frequency and duration of practicing the exercises (recorded in a log and responses to text messages)8 weeks

Other

MeasureTime frame
Quality of life, as assessed by NIH PROMIS instruments at the beginning, midpoint and end of the study0, 4 and 8 weeks
Distress, as assessed by NCCN Distress Thermometer and NIH PROMIS instruments at the beginning, midpoint and end of the study0, 4 and 8 weeks
Anxiety, as assessed by NCCN Distress Thermometer and NIH PROMIS instruments at the beginning, midpoint and end of the study0, 4 and 8 weeks
Depression, as assessed by NCCN Distress Thermometer and NIH PROMIS instruments at the beginning, midpoint and end of the study0, 4 and 8 weeks
Fatigue, as assessed by NCCN Distress Thermometer and NIH PROMIS instruments at the beginning, midpoint and end of the study0, 4 and 8 weeks
Sleep quality, as assessed by NCCN Distress Thermometer and NIH PROMIS instruments at the beginning, midpoint and end of the study0, 4 and 8 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026